Bibliography
- Baker-Glenn C, Burdick D J, Chambers M, Aminopyrimidine derivatives as LRRK2 modulators and their preparation and use for the treatment of Parkinson's disease. WO2011151360 A1 20111208; 2011
- Chen H, Chan BK, Drummond J, Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling. J Med Chem 2012;55:5536-45
- Choi HG, Zhang J, Deng X, Brain penetrant LRRK2 inhibitor. ACS Med. Chem Lett 2012;3:658-62
- Estrada AA, Liu X, Baker-Glenn C Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem 2012; 55:9416-9433